RSS

Diagnostic criteria for renovascular disease: where are we now?

21 Ago

Diagnostic criteria for renovascular… [Nephrol Dial Transplant. 2012] – PubMed – NCBI.

una bella review da leggere. grazie rachele
Nephrol Dial Transplant. 2012 Jul;27(7):2657-63.

Diagnostic criteria for renovascular disease: where are we now?

Source

Correspondence and offprint requests to: Stephen C. Textor; E-mail: stextor@mayo.edu.

Abstract

Renovascular disease, especially atherosclerotic renal artery stenosis (ARAS) in older subjects, is commonly encountered in clinical practice. This is at least in part due to the major advances in non-invasive imaging techniques that allow greater diagnostic sensitivity and accuracy than ever before. Despite increased awareness of ARAS, renal revascularization is less commonly performed, likely as a result of several prospective, randomized, clinical trials which fail to demonstrate major benefits of renal revascularization beyond medical therapy alone. Primary care physicians are less likely to investigate renovascular disease and nephrologists likely see more patients after a period of unsuccessful medical therapy with more advanced ARAS. The goal of this review is to revisit current diagnostic and therapeutic paradigms in order to characterize more clearly which patients will likely benefit from further evaluation and intensive treatment of renal artery stenosis.

 
Lascia un commento

Pubblicato da su 21 agosto 2012 in emodialisi e DP, epidemiologia CKD

 

Tag:

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione /  Modifica )

Google+ photo

Stai commentando usando il tuo account Google+. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: